These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 9011452)
1. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA). Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452 [TBL] [Abstract][Full Text] [Related]
2. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Lanzini A; De Tavonatti MG; Panarotto B; Scalia S; Mora A; Benini F; Baisini O; Lanzarotto F Gut; 2003 Sep; 52(9):1371-5. PubMed ID: 12912872 [TBL] [Abstract][Full Text] [Related]
3. Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test. Eusufzai S; Ericsson S; Cederlund T; Einarsson K; Angelin B Gut; 1991 Sep; 32(9):1044-8. PubMed ID: 1916489 [TBL] [Abstract][Full Text] [Related]
4. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Marteau P; Chazouilléres O; Myara A; Jian R; Rambaud JC; Poupon R Hepatology; 1990 Nov; 12(5):1206-8. PubMed ID: 2227819 [TBL] [Abstract][Full Text] [Related]
5. Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function. Nyhlin H; Brydon G; Danielsson A; Westman S Hepatogastroenterology; 1984 Aug; 31(4):187-91. PubMed ID: 6479839 [TBL] [Abstract][Full Text] [Related]
6. Influence of cholestasis on absorption of ursodeoxycholic acid. Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843 [TBL] [Abstract][Full Text] [Related]
7. [Results of the 75selenium homotaurocholic acid retention test (SeHCAT test) in diagnosis of diarrhea]. Balzer K; Schmitt G; Reiners C; Goebell H Med Klin (Munich); 1995 Jan; 90(1):27-32. PubMed ID: 7885300 [TBL] [Abstract][Full Text] [Related]
8. Intestinal bile acid malabsorption in cystic fibrosis. O'Brien S; Mulcahy H; Fenlon H; O'Broin A; Casey M; Burke A; FitzGerald MX; Hegarty JE Gut; 1993 Aug; 34(8):1137-41. PubMed ID: 8174969 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 75SeHCAT retention half-life and fecal content of individual bile acids in patients with chronic diarrheal disorders. Scheurlen C; Kruis W; Büll U; Stellaard F; Lang P; Paumgartner G Digestion; 1986; 35(2):102-8. PubMed ID: 3770317 [TBL] [Abstract][Full Text] [Related]
10. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate. Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957 [TBL] [Abstract][Full Text] [Related]
11. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Brydon WG; Nyhlin H; Eastwood MA; Merrick MV Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):117-23. PubMed ID: 8723414 [TBL] [Abstract][Full Text] [Related]
12. Plasma lathosterol as a screening test for bile acid malabsorption due to ileal resection: correlation with 75SeHCAT test and faecal bile acid excretion. Färkkilä MA; Kairemo KJ; Taavitsainen MJ; Strandberg TA; Miettinen TA Clin Sci (Lond); 1996 Apr; 90(4):315-9. PubMed ID: 8777839 [TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment. Stiehl A Ital J Gastroenterol; 1995 May; 27(4):193-5. PubMed ID: 8520037 [TBL] [Abstract][Full Text] [Related]
14. Bile acid malabsorption: a complication of conduit surgery. Durrans D; Wujanto R; Carroll RN; Torrance HB Br J Urol; 1989 Nov; 64(5):485-8. PubMed ID: 2611619 [TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Poupon R; Poupon RE Pharmacol Ther; 1995 Apr; 66(1):1-15. PubMed ID: 7630925 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Jazrawi RP; de Caestecker JS; Goggin PM; Britten AJ; Joseph AE; Maxwell JD; Northfield TC Gastroenterology; 1994 Jan; 106(1):134-42. PubMed ID: 8276175 [TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728 [TBL] [Abstract][Full Text] [Related]
18. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Borghede MK; Schlütter JM; Agnholt JS; Christensen LA; Gormsen LC; Dahlerup JF Eur J Intern Med; 2011 Dec; 22(6):e137-40. PubMed ID: 22075299 [TBL] [Abstract][Full Text] [Related]
20. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study. Sciarretta G; Furno A; Morrone B; Malaguti P Am J Gastroenterol; 1994 Jul; 89(7):1058-61. PubMed ID: 8017365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]